HEIDI HENSON, CFO at Kura Oncology, holds ― shares in Kura Oncology (Ticker: KURA), holds 0.00 shares in Pardes Biosciences (Ticker: PRDS), holds ― shares in PepGen Inc. (Ticker: PEPG). Most recently, HEIDI HENSON ― shares of Kura Oncology on ― for an estimated value of ―.
HEIDI HENSON latest transaction was an Uninformative Buy of ―.
What was HEIDI HENSON's most profitable transaction?
HEIDI HENSON’s most profitable transaction was an Informative Buy of CATX stock on December 6, 2024. The return on the trade was -24.20%.
What is HEIDI HENSON's role in Kura Oncology?
HEIDI HENSON's role in Kura Oncology is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.